57.40
0.00%
Close of 9 Nov 2026, in TWD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Norbel Baby Co
Its shares trade on Taipei Exchange under the ticker 6844.TWO. It has been listed since 12 November 2021. In the fiscal year to 31 December 2025, it reported revenue of TWD 3.45bn and net income of TWD 87.8m. At that date it held total assets of TWD 4.92bn and shareholders' equity of TWD 3.19bn.
Norbel Baby Co., Ltd. engages in the distribution and sales of cosmeceuticals and pharmaceuticals under the brand name Ding Ding Pharmacy. The company is headquartered in Kaohsiung, Kaohsiung. The company went IPO on 2021-11-12. The firm is engaged in the sale of professional pharmaceuticals, medical care, health care, women's and children's products, medical beauty products and related consulting services. The firm is engaged in the provision of sales and services for women's and children's products, pharmaceuticals, and health care products. The firm's products include baby milk powder, diapers, maternity and baby products and other women's and infant products; health care drugs such as health food and drugs for children, adults and silver hair; health care products such as adult milk powder and diapers, medical equipment, and home living products. The firm sells its products mainly in China.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Consumer Staples Distribution & Retail
- Listed since
- 12 Nov 2021
- Website
- norbelbaby.com.tw ↗
Leadership
Pay as last reported
- Houng-Pei YangChairman of the Board, since 2024
- Ms. Wang-Shen HsuVice Chairman of the Board, since 2021
- Mr. Yao-Hung HsuGeneral Manager, Director
- Huiqi FangHead of Finance & Accounting
- Mr. Chih-Cheng WuCorporate Governance Officer
- Shenglong ShenChief Strategy Officer, Director, since 2024
- Mr. Hua-Tsung WuDirector
- Mr. Bo Chen HuangIndependent Director
- Mr. Pao-Lin HuangIndependent Director
- Mr. Chi-Kuo TsengIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Ding Ding Pharmacy distributes cosmeceuticals and pharmaceuticals in the retail sector.
- The company sells baby milk powder and diapers to consumers in China.
- Norbel Baby offers consulting services for women's and children's health care products.
Weaknesses
- The firm relies heavily on sales within the China market segment.
- Norbel Baby Co Ltd lacks diversification beyond its core retail operations.
- The company's product range is limited to specific health and baby items.
Opportunities
- Expanding the medical beauty products line could attract new customer segments.
- Growing demand for health food and drugs supports revenue growth potential.
- Increasing interest in adult milk powder presents a new sales avenue.
Threats
- Concentration in the China market exposes the firm to regional economic risks.
- Competitors in the retail sector may offer lower prices for baby products.
- Changes in health care regulations could impact the sale of pharmaceuticals.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.